Show simple item record

Ledipasvir/Sofosbuvir plus Ribavirin (LDV/SOF+RBV) for 12 Weeks in Decompensated HCV Genotype 1 Patients: SOLAR-1 and SOLAR-2 Studies Compared to a Real-world Dataset

dc.contributor.authorCharlton, Men_US
dc.contributor.authorCheung, MCMen_US
dc.contributor.authorManns, Men_US
dc.contributor.authorSajed, Nen_US
dc.contributor.authorTroke, PJFen_US
dc.contributor.authorSpellman, Jen_US
dc.contributor.authorCopans, Aen_US
dc.contributor.authorArterburn, Sen_US
dc.contributor.authorBrainard, DMen_US
dc.contributor.authorIrving, WLen_US
dc.contributor.authorFoster, GRen_US
dc.date.accessioned2020-07-17T15:41:16Z
dc.date.issued2017-05en_US
dc.identifier.issn0041-1337en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/65720
dc.format.extent92 - 92en_US
dc.titleLedipasvir/Sofosbuvir plus Ribavirin (LDV/SOF+RBV) for 12 Weeks in Decompensated HCV Genotype 1 Patients: SOLAR-1 and SOLAR-2 Studies Compared to a Real-world Dataseten_US
dc.typeConference Proceeding
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436895400172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue5en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume101en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record